Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2012 08:16 ET | Source: Zevra Therapeutics

KemPharm, Inc. Presents Key Findings for Novel Hydromorphone Prodrug at 2012 International Conference on Opioids

NORTH LIBERTY, Iowa, June 11, 2012 (GLOBE NEWSWIRE) -- KemPharm, Inc. today presented key preclinical findings from KP511, the Company's first-in-class oral hydromorphone prodrug, at the 2012...
May 22, 2012 08:01 ET | Source: Zevra Therapeutics

KemPharm Inc. Focuses on Advanced Pain Management Franchise

NORTH LIBERTY, Iowa, May 22, 2012 (GLOBE NEWSWIRE) -- KemPharm, Inc. ("KemPharm"), a clinical-stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat...
October 26, 2011 08:05 ET | Source: Zevra Therapeutics

KemPharm, Inc. Expands Pain Therapy Pipeline With Discovery of KP511

NORTH LIBERTY, Iowa, Oct. 26, 2011 (GLOBE NEWSWIRE) -- KemPharm, Inc. today announced it plans to initiate development of its recently identified lead compound KP511, a first-in-class oral prodrug of...
August 30, 2011 08:11 ET | Source: Zevra Therapeutics

KemPharm, Inc. Expands ADHD Pipeline With Discovery of KP415

NORTH LIBERTY, Iowa, Aug. 30, 2011 (GLOBE NEWSWIRE) -- KemPharm, Inc. ("KemPharm") today announced it plans to initiate development of its recently identified lead compound KP415, a first-in-class...